• Ep. 251 - Eyes on the target: a Back to School Overview

  • Sep 7 2024
  • Duración: 32 m
  • Podcast

Ep. 251 - Eyes on the target: a Back to School Overview

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this year’s series of Back to School essays, BioCentury’s editors ask whether the era of human first, causal biology and personalized medicine can reshape drug discovery to solve the weakest link in biotech — translation to the clinic. On a special edition of the BioCentury This Week podcast, the three authors of BioCentury’s 32nd Back to School edition, Editor in Chief Simone Fishburn, Executive Editor Selina Koch, and Executive Director of Biopharma Intelligence Lauren Martz, discuss how industry can solve its biggest bottleneck.

    The editors zero in on inflammation and immunology, specifically how immunoproteomics upstage genomics in I&I target discovery, and neurology, notably how neuroscience companies are reducing to practice the concept of human-first discovery. Finally, they discuss the thread that runs through it all — precision medicine — and how biomarkers can help validate targets while bringing precision medicine to I&I and neurology.

    View full story: https://www.biocentury.com/article/653485


    00:00 - Introduction
    01:32 - Introducing Back to School
    10:42 - Validation Tools
    14:50 - I&I
    21:00 - Neurology
    27:19 - Precision Medicine

    Reach us by sending a text
    Más Menos
activate_Holiday_promo_in_buybox_DT_T2
Más Menos

Lo que los oyentes dicen sobre Ep. 251 - Eyes on the target: a Back to School Overview

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles